Anti B cell therapy (rituximab) in the treatment of autoimmune diseases

Current Opinion in Pharmacology
Hanadi Kazkaz, David Isenberg

Abstract

B cells play an important role in the pathogenesis of many autoimmune diseases. Selective targeting of these cells has been recently achieved using a chimeric monoclonal antibody against the pan B cell surface marker CD20 (rituximab). This antibody was originally developed for the treatment of non-Hodgkin's lymphoma. It was found to be effective, well tolerated and had a very good safety profile. Recent studies have demonstrated the efficacy of rituximab in several refractory autoimmune disorders including rheumatoid arthritis, systemic lupus erythematosus, immune thrombocytopenic purpura, chronic cold agglutinin disease, IgM-mediated neuropathies and mixed cryoglobulinemia.

Citations

Jan 5, 2006·Indian Journal of Pediatrics·Mani Mohindru, Amit Verma
Aug 29, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Stephen D Marks, Mary McGraw
Oct 11, 2005·Autoimmunity Reviews·Antonio La CavaBevra H Hahn
Aug 10, 2007·The New England Journal of Medicine·Pascal JolyPhilippe Musette
Oct 24, 2008·Brain : a Journal of Neurology·S JariusW Kristoferitsch
May 18, 2005·Annals of the Rheumatic Diseases·R H StraubM Cutolo
Feb 14, 2013·The Review of Diabetic Studies : RDS·Benno WeigmannCarolin Daniel
Mar 11, 2005·Expert Opinion on Therapeutic Targets·Walid MouradMoncef Zouali
Mar 1, 2007·Expert Review of Clinical Immunology·Ellis KingJonathan P Moorman
Nov 20, 2013·Autoimmunity·Van Phi LuuAlbert Zlotnik
Apr 20, 2010·The American Journal of Medicine·Francesco IannuzzellaGiovanni Garini
Aug 18, 2009·Cancer Treatment Reviews·Voravit RatanatharathornJoseph P Uberti
Oct 23, 2008·Oral and Maxillofacial Surgery Clinics of North America·Wendell A EdginRonald E Grimwood
Jun 2, 2005·American Journal of Hematology·Morie A Gertz
Sep 3, 2005·American Journal of Hematology·Muzaffar H QazilbashRichard Champlin
Oct 4, 2005·Arthritis and Rheumatism·Stephen D MarksKjell Tullus
Sep 18, 2009·Annals of the New York Academy of Sciences·Joaquim Polido-PereiraJoão Eurico Fonseca
May 28, 2008·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Jürgen RechHendrik Schulze-Koops
Dec 2, 2005·Arthritis and Rheumatism·Alexandra P TreschowShohreh Issazadeh-Navikas
Feb 1, 2007·Journal of Cellular Biochemistry·Magnus JohanssonLisa M Coussens
Apr 21, 2006·Immunological Reviews·Angela Bauch, Giulio Superti-Furga
Feb 26, 2013·British Journal of Clinical Pharmacology·Florent PuissetJacques Pourrat
Nov 14, 2006·Journal of the American Academy of Dermatology·Hope V DinhH Miles Prince
Aug 16, 2006·Journal of the American Academy of Dermatology·Abdul Kader El TalA Razzaque Ahmed
Nov 2, 2005·Journal of Autoimmunity·Marc FeldmannR N Maini
Nov 18, 2005·Experimental Eye Research·Hyuncheol KimMichael R Robinson
Mar 21, 2015·American Journal of Clinical Dermatology·A Razzaque Ahmed, Shawn Shetty
Jul 12, 2005·Veterinary Pathology·C M JubalaJ F Modiano
Jun 3, 2005·Nature·Marc Feldmann, Lawrence Steinman
Mar 10, 2011·Journal of Clinical Neuromuscular Disease·Prinyarat BurusnukulEdward J Cupler
Sep 23, 2008·Ophthalmic Plastic and Reconstructive Surgery·James A Garrity, Eric L Matteson
Jun 2, 2011·Nature Reviews. Drug Discovery·Frank Waldron-Lynch, Kevan C Herold
May 18, 2019·International Journal of Molecular Sciences·Julie SanchezMartin J Stone
Jun 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michele L FieldsJan Erikson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Luigi Virgolini, Vanda Marzocchi
Nature Reviews. Immunology
Andrew C Chan, Paul J Carter
The New England Journal of Medicine
Mark D PescovitzType 1 Diabetes TrialNet Anti-CD20 Study Group
© 2022 Meta ULC. All rights reserved